DIETARY AND SERUM MAGNESIUM LEVELS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, CORONARY-ARTERY DISEASE AND NONCARDIAC DIAGNOSES

Objective: To study the relation of dietary and serum levels of magnesium (Mg) in acute myocardial infarction (AMI) and its complications in relation to noncardiac diagnoses. Methodology: Case control study in a primary and secondary care center for AMI patients. The study included 460 subjects with definite AMI (n = 335, group A), possible AMI (n = 64, group B), unstable angina (n = 19, group C) and controls with noncardiac chest pain (n = 42, group D). Demographic variables, dietary intake, and clinical and biochemical data were compared. Mean age, sex, body weight, and body mass index were comparable in all the groups. Results: Dietary fat and cholesterol intakes were significantly higher and carbohydrate intakes were lower in group A, B and C patients with coronary artery disease compared to control group D. Dietary consumption of Mg was comparable in all groups; however, in 85 patients in group A(272.5 mg/day) and 17 in group B (280.4 mg/day) in whom ventricular arrhythmias were present, Mg intake was relatively lower compared to control group D (316.6 mg/day). Serum Mg levels in group A (1.66 mEq/L), B(1.65 mEq/L), and C(1.66 mEq/L) were within normal (1.74 mEq/L) limits, but were significantly lower than in control group D. Conclusions: Lower serum Mg in group A, B and C patients was attributed to increased demand during AMI, although in patients with complications (ventricular arrhythmias), Mg deficiency may in part result from relatively lower Mg intake, a hypothesis which requires further study.